MSD’s investigational two-drug HIV combination has been proven safe, efficacious and non-inferior to current standard of care ...

The improvement was driven largely by a 6.9% increase in work exits from Jobseeker Support, alongside a slight drop in the ...

During the second set of Tuesday’s volleyball match, Maryland School for the Deaf outside hitter Maliyah Coleman dove to the floor and rolled out of Emma Le’s path so the Orioles setter could move ...

LOUISVILLE, Ky. — Flash flooding is impacting areas around Louisville. The area is under a flash flood warning until 2:15 p.m. According to MSD, six inches of moving water can knock you down while one ...

"Under the SSA, Australian citizens who migrate to New Zealand, and meet the criteria for New Zealand benefits and pensions ...

Speaking on popular web series, Breakfast with Champions, the 34-year-old spinner recalled how how he once followed the CSK ...

Leticia Detrow didn’t have much of a choice. Her sprinting times had plateaued. And, unbeknownst to her, Randy Shank, her track coach at Maryland School for the Deaf, had signed her up for a pair of ...

RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of its minority ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Patients with untreated advanced melanoma do not appear to gain a survival advantage from the addition of a cancer vaccine to pembrolizumab, suggests a trial.

Belzutifan, pembrolizumab, and lenvatinib combination showed superior efficacy in advanced ccRCC, with high overall response ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...